|
1
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishio K, Nakamura T, Koh Y, Suzuki T,
Fukumoto H and Saijo N: Drug resistance in lung cancer. Curr Opin
Oncol. 11:109–115. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki T, Nishio K and Tanabe S: The MRP
family and anticancer drug metabolism. Curr Drug Metab. 2:367–377.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nordstrom DK: Public health. Worldwide
occurrences of arsenic in ground water. Science. 296:2143–2145.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rao Y, Li R and Zhang D: A drug from
poison: How the therapeutic effect of arsenic trioxide on acute
promyelocytic leukemia was discovered. Sci China Life Sci.
56:495–502. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lengfelder E, Hofmann WK and Nowak D:
Impact of arsenic trioxide in the treatment of acute promyelocytic
leukemia. Leukemia. 26:433–442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang N, Wu ZM, McGowan E, Shi J, Hong ZB,
Ding CW, Xia P and Di W: Arsenic trioxide and cisplatin synergism
increase cytotoxicity in human ovarian cancer cells: Therapeutic
potential for ovarian cancer. Cancer Sci. 100:2459–2464. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Helm CW and States JC: Enhancing the
efficacy of cisplatin in ovarian cancer treatment-could arsenic
have a role. J Ovarian Res. 2:22009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng CY, Lam SK, Li YY, Fong BM, Mak JC
and Ho JC: Combination of arsenic trioxide and chemotherapy in
small cell lung cancer. Lung Cancer. 82:222–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leslie EM: Arsenic-glutathione conjugate
transport by the human multidrug resistance proteins (MRPs/ABCCs).
J Inorg Biochem. 108:141–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong WS, Saijo N, Sasaki Y, Minato K,
Nakano H, Nakagawa K, Fujiwara Y, Nomura K and Twentyman PR:
Establishment and characterization of cisplatin-resistant sublines
of human lung cancer cell lines. Int J Cancer. 41:462–467. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uemura M, Suzuki T, Nishio K, Chikuma M
and Komeda S: An in vivo highly antitumor-active
tetrazolato-bridged dinuclear platinum (II) complex largely
circumvents in vitro cisplatin resistance: Two linkage isomers
yield the same product upon reaction with 9-ethylguanine but
exhibit different cytotoxic profiles. Metallomics. 4:686–692. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mukai Y, Togawa T, Suzuki T, Ohata K and
Tanabe S: Determination of homocysteine thiolactone and
homocysteine in cell cultures using high-performance liquid
chromatography with fluorescence detection. J Chromatogr B Analyt
Technol Biomed Life Sci. 767:263–268. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Habig WH, Pabst MJ, Fleischner G,
Gatmaitan Z, Arias IM and Jakoby WB: The identity of glutathione
S-transferase B with ligandin, a major binding protein of liver.
Proc Natl Acad Sci USA. 71:3879–3882. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshikawa M, Ikegami Y, Hayasaka S, Ishii
K, Ito A, Sano K, Suzuki T, Togawa T, Yoshida H and Soda H: Novel
camptothecin analogues that circumvent ABCG2-associated drug
resistance in human tumor cells. Int J Cancer. 110:921–927. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kurokawa H, Ishida T, Nishio K, Arioka H,
Sata M, Fukumoto H, Miura M and Saijo N: Gamma-glutamylcysteine
synthetase gene overexpression results in increased activity of the
ATP-dependent glutathione S-conjugate export pump and cisplatin
resistance. Biochem Biophys Res Comm. 216:258–264. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishikawa T, Bao JJ, Yamane Y, Akimaru K,
Frindrich K, Wright CD and Kuo MT: Coordinated induction of
MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals
in human leukemia cells. The Journal of biological chemistry.
271:14981–14988. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naredi P, Heath DD, Enns RE and Howell SB:
Cross-resistance between cisplatin, antimony potassium tartrate and
arsenite in human tumor cells. J Clin Invest. 95:1193–1198. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki T, Ohata S, Togawa T, Himeno S and
Tanabe S: Arsenic accumulation decreased in metallothionein null
Cisplatin-resistant cell lines. J Toxicol Sci. 32:321–328. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakaoka T, Ota A, Ono T, Karnan S, Konishi
H, Furuhashi A, Ohmura Y, Yamada Y, Hosokawa Y, Kazaoka Y, et al:
Combined arsenic trioxide-cisplatin treatment enhances apoptosis in
oral squamous cell carcinoma cells. Cell Oncol (Dordr). 37:119–129.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Shen J, Carbrey JM, Mukhopadhyay R,
Agre P and Rosen BP: Arsenite transport by mammalian
aquaglyceroporins AQP7 and AQP9. Proc Natl Acad Sci USA.
99:6053–6058. 2002. View Article : Google Scholar : PubMed/NCBI
|
